glycyrrhizic acid has been researched along with Chronic Hepatitis C in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 15 (57.69) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carreño, V | 1 |
| Akuta, N; Arase, Y; Fukushima, T; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y | 1 |
| Matsumura, H; Matsuoka, S; Moriyama, M; Nakamura, H; Nirei, K | 1 |
| Rino, Y; Yamamoto, N; Yukawa, N | 1 |
| Alves, K; Badri, PS; Ding, B; Dutta, S; Menon, RM; Redman, R; Rodrigues, L; Uchiyama, N; Zha, J | 1 |
| Aoyama, T; Horiuchi, A; Kiyosawa, K; Komatsu, M; Nagaya, T; Okaniwa, S; Tanaka, E; Tanaka, N; Yamaura, T; Yokoyama, T; Yoshizawa, K | 1 |
| Bertot, LC; del Rosario Abreu Vazquez, M; Fabian, LG; Forment, GR; Garcia, AY; Gomez, EV; Perez, YM; Sanchez, HV; Soler, EA | 1 |
| Dienes, HP; Goldin, R; Hehnke, U; Inoue, H; Khomutjanskaja, N; Manns, MP; Roskams, T; Singer, A; Wedemeyer, H | 1 |
| Coon, JT; Ernst, E | 1 |
| Kobayashi, T; Okamoto, T; Yoshida, S | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y | 1 |
| Brouwer, JT; Gerken, G; Hansen, BE; Huber, R; Kullak-Ublick, GA; Lagging, M; Nevens, F; Orlent, H; Schalm, SW; Tielemans, WC; Westin, J; Willems, M; Zeuzem, S; Zondervan, PE | 1 |
| Hansen, BE; Ikeda, K; Schalm, SW; Suzuki, H; Veldt, BJ; Verhey, E | 1 |
| Fukumoto, K; Kanemasa, K; Sakai, K; Sumida, Y; Yoshida, N | 1 |
| Brouwer, JT; de Man, RA; Schalm, SW; van Rossum, TG; Vulto, AG | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Kumada, H; Murashima, N; Saitoh, S; Suzuki, Y; Tsubota, A | 1 |
| Brouwer, JT; Hop, WC; Niesters, HG; Schalm, SW; van Rossum, TG; Vulto, AG | 1 |
| Hop, WC; Schalm, SW; van Rossum, TG; Vulto, AG | 2 |
| Harada, H; Kamitsukasa, H; Kojima, H; Murai, S; Tokita, H; Yagura, M | 1 |
| Kasahara, A | 1 |
| Akagi, S; Hamamoto, S; Kinoshita, Y; Kohge, N; Mishiro, T; Moritani, M; Sato, S; Uchida, Y; Watanabe, M | 1 |
| Iino, S; Miyakawa, Y | 1 |
| Boomsma, F; de Jong, FH; Hop, WC; Schalm, SW; van Rossum, TG | 1 |
| DeJongh, J; Mensinga, T; Meulenbelt, J; Ploeger, B; Seinen, W; Sips, A | 1 |
| Hino, O; Kajino, K; Okamoto, T | 1 |
7 review(s) available for glycyrrhizic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.
Topics: Animals; Antiviral Agents; Biological Products; Contraindications; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Iron; Ursodeoxycholic Acid | 2014 |
Does herbal medicine reduce the risk of hepatocellular carcinoma?
Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drugs, Chinese Herbal; Fatty Liver; Fluorenes; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Preparations; Sofosbuvir; Tablets | 2015 |
Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review.
Topics: Animals; Antioxidants; Cattle; Complementary Therapies; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Medicine, Chinese Traditional; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Thymus Gland; Tissue Extracts; Zinc | 2004 |
Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas.
Topics: Alanine Transaminase; Animals; Anticarcinogenic Agents; Carcinoma, Hepatocellular; Coumarins; Furocoumarins; Glycyrrhizic Acid; Hepatitis C, Chronic; Interferons; Mice; Structure-Activity Relationship | 2005 |
Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.
Topics: Antiviral Agents; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans | 1998 |
Treatment strategies for chronic hepatitis C virus infection.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Iron Overload; Liver Neoplasms; Ribavirin; Treatment Outcome; Ursodeoxycholic Acid | 2000 |
The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Digestive System; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Liver; Models, Biological; Molecular Structure | 2001 |
9 trial(s) available for glycyrrhizic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Incidence of hepatocellular carcinoma reduced by phlebotomy treatment in patients with chronic hepatitis C.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Phlebotomy; Platelet Count; Ursodeoxycholic Acid | 2015 |
Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections.
Topics: Aged; Alanine Transaminase; Anti-Inflammatory Agents; Bloodletting; Combined Modality Therapy; Female; Ferritins; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2009 |
Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.
Topics: Antioxidants; Ascorbic Acid; Cytokines; Dietary Supplements; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Immunologic Factors; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pantothenic Acid; Placebos; Plant Extracts; Treatment Outcome; Vitamin B 12 Deficiency; Vitamin B 6; Zinc | 2010 |
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Double-Blind Method; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Placebos; Treatment Outcome | 2012 |
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Drug Monitoring; Female; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Quality of Life; RNA, Viral; Treatment Outcome | 2006 |
Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
Topics: Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Cholagogues and Choleretics; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Glycyrrhizic Acid; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Time Factors; Treatment Outcome; Ursodeoxycholic Acid; Viremia | 1999 |
Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Infusions, Intravenous; Liver Function Tests; Male; Middle Aged | 1999 |
Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection.
Topics: Adult; Aged; Antiviral Agents; Area Under Curve; Chromatography, High Pressure Liquid; Female; Glycyrrhizic Acid; Half-Life; Hepatitis C, Chronic; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Regression Analysis | 1999 |
Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.
Topics: Adult; Aged; Alanine Transaminase; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Europe; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Injections, Intravenous; Male; Middle Aged; Polymerase Chain Reaction; RNA, Viral; Statistics, Nonparametric; Treatment Outcome | 2001 |
10 other study(ies) available for glycyrrhizic acid and Chronic Hepatitis C
| Article | Year |
|---|---|
Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov model.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Male; Markov Chains; Middle Aged; Young Adult | 2014 |
Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects.
Topics: Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Japan; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Proline; Ritonavir; Sulfonamides; Ursodeoxycholic Acid; Valine; Young Adult | 2015 |
A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Incidence; Injections, Intravenous; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Liver Neoplasms; Long-Term Care; Male; Middle Aged; Multivariate Analysis; Probability; Prognosis; Recombinant Proteins; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2006 |
Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Incidence; Injections, Intravenous; Interferons; Japan; Liver Neoplasms; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2006 |
[Utility of a little phlebotomy intermittently just before intravenous injection of glycyrrhizin for patients with chronic hepatitis C].
Topics: Aged; Alanine Transaminase; Female; Ferritins; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Injections, Intravenous; Male; Middle Aged; Phlebotomy | 2007 |
Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepatitis C; Hepatitis C, Chronic; Humans; Injections, Intramuscular; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Procollagen; Retrospective Studies; RNA, Viral; Ursodeoxycholic Acid | 2000 |
Report of a case showing a recovery from liver cirrhosis to chronic hepatitis, type C, after glycyrrhizin injection for 2 years and a sustained response by the following interferon therapy.
Topics: Adult; Drug Therapy, Combination; Female; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Injections; Interferon-beta; Laparoscopy; Liver; Liver Cirrhosis | 2001 |
Toward prevention of hepatocellular carcinoma developing in chronic hepatitis C.
Topics: Carcinoma, Hepatocellular; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Hyperaldosteronism; Liver Neoplasms | 2001 |
'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Aged; Aldosterone; Blood Pressure; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Female; Follow-Up Studies; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Hydrocortisone; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Injections, Intravenous; Male; Middle Aged | 2001 |
Hepatoprotective drugs for the treatment of virus-induced chronic hepatitis: from hypercarcinogenic state to hypocarcinogenic state.
Topics: Alanine Transaminase; Carcinoma, Hepatocellular; Coumarins; Glycyrrhizic Acid; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Neoplasms; Protective Agents | 2001 |